Frequency and outcomes of primary central sleep apnea in a population-based study
- PMID: 32044555
- PMCID: PMC9272740
- DOI: 10.1016/j.sleep.2019.12.008
Frequency and outcomes of primary central sleep apnea in a population-based study
Abstract
Background: Primary central sleep apnea (PCSA) is believed to be rare and data regarding its prevalence and long-term outcomes are sparse. We used the Rochester Epidemiology Project (REP) resources to identify all Olmsted County, Minnesota, residents with an incident diagnosis of PCSA and their clinical outcomes.
Methods: We searched the REP database for all residents with polysomnography (PSG)-confirmed diagnoses of central sleep apnea (CSA) between 2007 and 2015. From these, we reviewed the PSGs and medical records to find those who had PCSA based upon accepted diagnostic criteria. Data based on detailed review of the medical records, including all clinical notes and tests were recorded for analysis.
Results: Of 650 patients identified with CSA, 25 (3.8%; 23 male) had PCSA, which was severe in most patients (n = 16, 64%). Of those, 23 (92%) patients were prescribed and 18/23 (78.2%) adherent to positive airway pressure therapy. Median duration of follow-up was 4.4 years (IQR:4.2). Four (16%) patients were subsequently diagnosed with cardiac arrhythmias, one (4%) with unstable angina, two (8%) with heart failure, five (20%) with mild cognitive impairment (MCI)/dementia and two (8%) with depression. Six (25%) patients died (median time to death = 5 years; IQR:4.8), three of whom had Lewy body dementia.
Conclusions: In this population-based study, PCSA was rare and when present, was severe in a majority of patients. The mortality rate was high. Most frequently observed disorders during follow-up were mild cognitive impairment (MCI)/dementia followed by cardiac arrhythmias; it is possible that these entities were present and not recognized prior to the diagnosis of PCSA.
Keywords: Cardiac arrhythmia; Dementia; Idiopathic central sleep apnea; Mild cognitive impairment; Mortality; Primary central sleep apnea.
Copyright © 2019 Elsevier B.V. All rights reserved.
Conflict of interest statement
The ICMJE Uniform Disclosure Form for Potential Conflicts of Interest associated with this article can be viewed by clicking on the following link:
Figures
Similar articles
-
Evaluation of the Impact of Body Position on Primary Central Sleep Apnea Syndrome.Arch Bronconeumol (Engl Ed). 2021 Jun;57(6):393-398. doi: 10.1016/j.arbr.2020.03.030. Arch Bronconeumol (Engl Ed). 2021. PMID: 34088390
-
Prevalence and risk factors for central sleep apnea in infants with laryngomalacia.Otolaryngol Head Neck Surg. 2014 Apr;150(4):677-83. doi: 10.1177/0194599814521379. Epub 2014 Feb 3. Otolaryngol Head Neck Surg. 2014. PMID: 24493785
-
Central sleep apnea on commencement of continuous positive airway pressure in patients with a primary diagnosis of obstructive sleep apnea-hypopnea.J Clin Sleep Med. 2007 Aug 15;3(5):462-6. J Clin Sleep Med. 2007. PMID: 17803008 Free PMC article.
-
Central Sleep Apnea.Clin Geriatr Med. 2021 Aug;37(3):469-481. doi: 10.1016/j.cger.2021.04.009. Epub 2021 Jun 4. Clin Geriatr Med. 2021. PMID: 34210451 Review.
-
Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations.Anesth Analg. 2015 Jun;120(6):1273-85. doi: 10.1213/ANE.0000000000000672. Anesth Analg. 2015. PMID: 25988636 Review.
Cited by
-
Predictors of Initial CPAP Prescription and Subsequent Course with CPAP in Patients with Central Sleep Apneas at a Single Center.Lung. 2023 Dec;201(6):625-634. doi: 10.1007/s00408-023-00657-z. Epub 2023 Nov 21. Lung. 2023. PMID: 37987861 Free PMC article.
-
Association Between Central Sleep Apnea and Left Atrial Enlargement in Snoring Patients with Preserved Ejection Fraction.Nat Sci Sleep. 2025 Mar 13;17:447-460. doi: 10.2147/NSS.S500562. eCollection 2025. Nat Sci Sleep. 2025. PMID: 40103651 Free PMC article.
-
Is idiopathic central sleep apnea a separate entity?J Clin Sleep Med. 2020 Dec 15;16(12):1999-2001. doi: 10.5664/jcsm.8926. J Clin Sleep Med. 2020. PMID: 33063658 Free PMC article.
-
Contribution of central sleep apnea to severe sleep apnea hypopnea syndrome.Sleep Breath. 2023 Oct;27(5):1839-1845. doi: 10.1007/s11325-023-02776-6. Epub 2023 Feb 28. Sleep Breath. 2023. PMID: 36849673 Free PMC article.
-
A Novel Portable Real-Time Low-Cost Sleep Apnea Monitoring System based on the Global System for Mobile Communications (GSM) Network.Med Biol Eng Comput. 2022 Feb;60(2):619-632. doi: 10.1007/s11517-021-02492-x. Epub 2022 Jan 14. Med Biol Eng Comput. 2022. PMID: 35029814 Free PMC article.
References
-
- American Academy of Sleep Medicine. International classification of sleep disorders. Darien, IL: American Academy of Sleep Medicine; 2014.
-
- Javaheri S. Treatment of central sleep apnea in heart failure. Sleep 2000;23(Suppl 4):S224–7. - PubMed
-
- Correa D, Farney RJ, Chung F, et al. Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations. Anesth Analg 2015;120(6):1273–85. - PubMed
-
- Mansukhani MPKB, Ramar K. International classification of sleep disorders 2 and American Academy of sleep medicine practice parameters for central sleep apnea. Sleep Med Clin 2014-March-01;9(1):1–11.